Physician profile
Michael C Widmer
NPI 1124092051
$2,420.30
in general payments reported to CMS, 2019-2025
20 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $143 · 2021: $215 · 2022: $428 · 2023: $420 · 2024: $281 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $484.27 | 2020-2025 | Repatha |
| Abbott Laboratories | $429.79 | 2019-2024 | Gallant |
| Novartis Pharmaceuticals Corporation | $309.44 | 2021-2025 | |
| Novo Nordisk INC | $223.53 | 2023-2024 | Wegovy, Ozempic |
| Medtronic Vascular, INC. | $166.99 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $120.00 | 2019 | |
| Ionis Pharmaceuticals, INC. | $107.28 | 2025 | |
| Abiomed | $106.55 | 2023 | Impella |
| Esperion Therapeutics, INC. | $98.38 | 2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $92.49 | 2025 | Evkeeza |
| Amarin Pharma, INC. | $54.57 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $51.39 | 2019-2024 | Wainua |
| Irhythm Technologies, INC. | $40.84 | 2020-2023 | Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $25.80 | 2023 | Inpefa |
| Kerecis Limited | $24.39 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.74 | 2023 | Watchman |
| United Therapeutics Corporation | $17.73 | 2019 | |
| Kestra Medical Technology Services, INC. | $17.47 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $16.65 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Widmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.